Time toxicity associated with early phase clinical trial participation
Open Access
- 16 November 2023
- Vol. 8 (6) , 102046
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Telehealth adoption in cancer clinical trials: An Australian perspectiveAsia-Pacific Journal of Clinical Oncology, 2022
- Time toxicity in early phase clinical trials (EP-CTs).Journal of Clinical Oncology, 2022
- Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022Annals of Oncology, 2022
- The Time Toxicity of Cancer TreatmentJournal of Clinical Oncology, 2022
- The Use of Telemedicine in Cancer Clinical Trials: Connect-Patient-to-Doctor Prospective StudyJMIR Cancer, 2022
- Impact of travel distance on outcomes for clinical trial patients: the Kinghorn Cancer Centre experienceInternal Medicine Journal, 2021
- Does Enrollment in Cancer Trials Improve Survival?Journal of the American College of Surgeons, 2013
- Life-expectancy of patients enrolled in phase 1 clinical trials: A systematic review of published prognostic modelsCritical Reviews in Oncology/Hematology, 2012
- Shared Decision-Making: Benefits, Barriers and Current Opportunities for ApplicationAustralasian Psychiatry, 2010
- Co‐ordinating ‘ethical’ clinical trials: the role of research coordinators in the contract research industrySociology of Health & Illness, 2006